Thorne HealthTech, Inc., a developer of innovative solutions for drug discovery, entered a two-year continuation of its collaboration with AstraZeneca for Thorne’s disease discovery platform for AZ’s further evaluation and to gain insight into additional uses for AZ molecules.   Thorne’s cloud-based AI disease discovery system integrates biology and chemistry evidence to create compound innovations for new product development in both nutrition and pharmaceutical fields. The system,...